Larchmont, NY, United States of America

John R Regan


 

 

Average Co-Inventor Count = 3.5

ph-index = 20

Forward Citations = 1,207(Granted Patents)

Forward Citations (Not Self Cited) = 1,195(Dec 10, 2025)


Location History:

  • Mamaroneck, NY (US) (1985 - 1988)
  • Collegeville, PA (US) (1995 - 1996)
  • Princeton, NJ (US) (1989 - 1997)
  • Larchmont, CT (US) (2009)
  • Larchmont, NY (US) (2000 - 2012)

Company Filing History:


Years Active: 1985-2012

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
CB2 Receptor Modulation
Glucocorticoid Mimetics
Cytokine Mediated Diseases
Anti-Inflammatory Agents
Aromatic Heterocyclic Compounds
HMG-CoA Reductase Inhibitors
Squalene Synthase Inhibitors
Polymers with Alkyl-Aryl Backbone
Cyclohexene Derivatives
Hypocholesterolemic Properties
Antihypertensive Derivatives
Carboxyalkyl Dipeptide Compounds
51 patents (USPTO):Explore Patents

Sure, I can help you with that. Here is an article about inventor John R Regan:

Title: John R Regan: Pioneering Innovations in Pharmaceutical Research

Introduction:

John R Regan, a renowned inventor based in Larchmont, NY, US, has dedicated his life to pushing the boundaries of what is possible in the world of inventions. With a remarkable portfolio of 28 patents, his passion for innovation has made him a true pioneer in the field.

Latest Patents:

Regan's latest patents include groundbreaking inventions such as Sulfone compounds which modulate the CB2 receptor and Glucocorticoid mimetics. These compounds hold significant promise in the treatment of inflammation and pain, as well as in modulating glucocorticoid receptor function for the management of various disease-states.

Career Highlights:

Having worked in esteemed companies like Boehringer Ingelheim Pharmaceuticals, Inc., and Aventis Pharma S.A., Regan has garnered extensive experience in pharmaceutical research and development. His innovative approach to drug discovery has led to the creation of impactful solutions that address unmet medical needs.

Collaborations:

Throughout his career, Regan has collaborated with industry experts such as Pier Francesco Cirillo and Eugene R Hickey. These collaborations have significantly contributed to the advancement of pharmaceutical science, emphasizing the importance of teamwork in driving innovation forward.

Conclusion:

In summary, John R Regan's relentless pursuit of creative ideas and his commitment to making a positive impact on the world through his inventions underscore his legacy as a visionary inventor. His work continues to inspire future generations of innovators to think outside the box and strive for excellence in the field of pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…